Metraipolis › archive › dc_ceac0573a969

Structure-Guided In-Use Stability Assessment of Monoclonal Antibody Tislelizumab — Europe PMC PMID:41155657

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41155657
DOI
10.3390/ph18101539
License (as archived)
solo-consultazione
Archived
2026-11-09T09:19:30.491Z
SHA-256 of the archived text
70c42b0e834a2e84a76924d6af4a9259178d2a8d57bca89a6fb6f0ba1fff4a9c
Stable URL of this page
https://metraipolis.com/documento/dc_ceac0573a969

How to cite

Structure-Guided In-Use Stability Assessment of Monoclonal Antibody Tislelizumab — Europe PMC PMID:41155657 — Europe PMC (en), https://europepmc.org/article/MED/41155657 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ceac0573a969 (Metraipolis archive dc_ceac0573a969, sha256 70c42b0e834a2e84a76924d6af4a9259178d2a8d57bca89a6fb6f0ba1fff4a9c)
BibTeX
@misc{dcceac0573a969,
  title = {Structure-Guided In-Use Stability Assessment of Monoclonal Antibody Tislelizumab — Europe PMC PMID:41155657},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41155657},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ceac0573a969; sha256 70c42b0e834a2e84a76924d6af4a9259178d2a8d57bca89a6fb6f0ba1fff4a9c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155657. Agents can read the archived copy with the MCP tool read_document.